Abstract
A 74-year-old Japanese woman was diagnosed with rheumatoid arthritis due to polyarthralgia. She was prescribed various disease-modifying anti-rheumatic drugs, but most of them were discontinued because of side effects or poor effectiveness. She was referred to our hospital in 2004, and etanercept was administered from June 2005. This resulted in rapid improvement of polyarthritis; however, she developed disorientation from February 2006. She was admitted to our hospital because of convulsions and loss of consciousness. She was diagnosed with progressive multifocal leukoencephalopathy on the basis of clinical symptoms and magnetic resonance imaging of the brain. In this significant and important case, leukoencephalopathy occurred during etanercept administration, and we refer to the risk of anti-TNFα drugs.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Guidelines for the proper use of anti-TNF drugs against rheumatoid arthritis. Japanese College of Rheumatology. http://www.ryumachi-jp.com/Ryumachi/Secure/kaiin/medical/brm_guideline.html
AK Imperato CO Bingham SuffixIII SB Abramson (2004) ArticleTitleOverview of benefit/risk of biological agents Clin Exp Rheumatol 22 IssueIDSuppl 35 S108–14 Occurrence Handle15552523 Occurrence Handle1:STN:280:DC%2BD2crns1aitQ%3D%3D
JC Roos AJ Ostor (2006) ArticleTitleAnti-tumor necrosis factor alpha therapy and the risk of JC virus infection Arthritis Rheum 54 381–2 Occurrence Handle16385537 Occurrence Handle10.1002/art.21688
KE Astrom EL Mancall EP Richardson SuffixJr (1958) ArticleTitleProgressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease Brain 81 93–111 Occurrence Handle13523006 Occurrence Handle10.1093/brain/81.1.93 Occurrence Handle1:STN:280:CyeD28rptVU%3D
BL Padgett DL Walker GM ZuRhein RJ Eckroade BH Dessel (1971) ArticleTitleCultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy Lancet 1 IssueID7712 1257–69 Occurrence Handle4104715 Occurrence Handle10.1016/S0140-6736(71)91777-6 Occurrence Handle1:STN:280:CS6B28%2FgvFw%3D
A Stolt K Sasnauskas P Koskela M Lehtinen J Dillner (2003) ArticleTitleSeroepideminology of the human polyomaviruses J Gen Virol 84 1499–504 Occurrence Handle12771419 Occurrence Handle10.1099/vir.0.18842-0 Occurrence Handle1:CAS:528:DC%2BD3sXks1GmtLw%3D
Kimura A, Ueyama H, Kimura N, Fujimoto S, Kumamoto T. Progressive multifocal leukoencephalopathy in an HTLV-1 carrier. Clin Neurol Neurosurg 2005 Oct 26; [Epub ahead of print]
F Ahmed T Aziz LD Kaufman (1999) ArticleTitleProgressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus J Rheumatol 26 1609–12 Occurrence Handle10405953 Occurrence Handle1:STN:280:DyaK1MzjsVChtw%3D%3D
K Subsai S Kanoksri C Siwaporn L Helen O Kanokporn P Wantana (2006) ArticleTitleNeurological complications in AIDS patients receiving HAART: a 2-year retrospective study Eur J Neurol 13 233–9 Occurrence Handle16618338 Occurrence Handle10.1111/j.1468-1331.2006.01178.x Occurrence Handle1:STN:280:DC%2BD283ht1KqsQ%3D%3D
A Antinori A Cingolani P Lorenzini ML Giancola I Uccella S Bossolasco et al. (2003) ArticleTitleClinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA) J Neurovirol 9 IssueIDSuppl 1 47–53 Occurrence Handle12709872 Occurrence Handle1:CAS:528:DC%2BD3sXksFOrsLw%3D
IJ Koralnik (2004) ArticleTitleNew insights into progressive multifocal leukoencephalopathy Curr Opin Neurol 17 365–70 Occurrence Handle15167073 Occurrence Handle10.1097/00019052-200406000-00019
G van Assche M Van Ranst R Sciot B Dubois S Vermeire M Noman et al. (2005) ArticleTitleProgressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 362–8 Occurrence Handle15947080 Occurrence Handle10.1056/NEJMoa051586 Occurrence Handle1:CAS:528:DC%2BD2MXms1Kntrk%3D
BK Kleinschmiedt-DeMasters KL Tyler (2005) ArticleTitleProgressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon γ-1a for multiple sclerosis N Engl J Med 353 369–74 Occurrence Handle10.1056/NEJMoa051782
A Langer-Gould SW Atlas AJ Green AW Bollen D Pelletier (2005) ArticleTitleProgressive multifocal leukoencephalopathy in a patient treated with natalizumab N Engl J Med 353 375–81 Occurrence Handle15947078 Occurrence Handle10.1056/NEJMoa051847 Occurrence Handle1:CAS:528:DC%2BD2MXms1Kntrc%3D
TA Yousry EO Major C Ryschkewitsch G Fahle S Fischer J Hou et al. (2006) ArticleTitleEvaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 924–33 Occurrence Handle16510746 Occurrence Handle10.1056/NEJMoa054693 Occurrence Handle1:CAS:528:DC%2BD28XitVertLs%3D
RM Ransohoff (2005) ArticleTitleNatalizumab and PML Nat Neurosci 8 1275 Occurrence Handle16189528 Occurrence Handle10.1038/nn1005-1275 Occurrence Handle1:CAS:528:DC%2BD2MXhtVeqsrfF
N Mohan ET Edwards TR Cupps PJ Oliverio G Sandberg H Crayton et al. (2001) ArticleTitleDemyelination occurring during anti-tumor necrosis factor α therapy for inflammatory arthritides Arthritis Rheum 44 2862–9 Occurrence Handle11762947 Occurrence Handle10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W Occurrence Handle1:CAS:528:DC%2BD38XislCltA%3D%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamamoto, M., Takahashi, H., Wakasugi, H. et al. Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis. Mod Rheumatol 17, 72–74 (2007). https://doi.org/10.1007/s10165-006-0530-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-006-0530-2